2-32141890-ATTT-ATT

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP6_Moderate

The NM_014946.4(SPAST):​c.1494-3delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0391 in 883,178 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.039 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SPAST
NM_014946.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.175

Publications

0 publications found
Variant links:
Genes affected
SPAST (HGNC:11233): (spastin) This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018]
SPAST Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 4
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, Ambry Genetics
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • SPAST-related motor disorder
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP6
Variant 2-32141890-AT-A is Benign according to our data. Variant chr2-32141890-AT-A is described in ClinVar as Benign. ClinVar VariationId is 2140310.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPASTNM_014946.4 linkc.1494-3delT splice_region_variant, intron_variant Intron 12 of 16 ENST00000315285.9 NP_055761.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPASTENST00000315285.9 linkc.1494-13delT intron_variant Intron 12 of 16 1 NM_014946.4 ENSP00000320885.3

Frequencies

GnomAD3 genomes
AF:
0.000265
AC:
39
AN:
147248
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000149
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000136
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00149
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000241
Gnomad OTH
AF:
0.000496
GnomAD2 exomes
AF:
0.0740
AC:
6822
AN:
92222
AF XY:
0.0752
show subpopulations
Gnomad AFR exome
AF:
0.0523
Gnomad AMR exome
AF:
0.113
Gnomad ASJ exome
AF:
0.0649
Gnomad EAS exome
AF:
0.0713
Gnomad FIN exome
AF:
0.0576
Gnomad NFE exome
AF:
0.0659
Gnomad OTH exome
AF:
0.0801
GnomAD4 exome
AF:
0.0391
AC:
34542
AN:
883178
Hom.:
0
Cov.:
24
AF XY:
0.0389
AC XY:
16899
AN XY:
434426
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0423
AC:
833
AN:
19680
American (AMR)
AF:
0.0618
AC:
1538
AN:
24868
Ashkenazi Jewish (ASJ)
AF:
0.0453
AC:
627
AN:
13856
East Asian (EAS)
AF:
0.0346
AC:
709
AN:
20506
South Asian (SAS)
AF:
0.0498
AC:
2338
AN:
46912
European-Finnish (FIN)
AF:
0.0416
AC:
1253
AN:
30142
Middle Eastern (MID)
AF:
0.0293
AC:
107
AN:
3656
European-Non Finnish (NFE)
AF:
0.0374
AC:
25725
AN:
688556
Other (OTH)
AF:
0.0403
AC:
1412
AN:
35002
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.244
Heterozygous variant carriers
0
5383
10766
16148
21531
26914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
996
1992
2988
3984
4980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000272
AC:
40
AN:
147328
Hom.:
0
Cov.:
32
AF XY:
0.000307
AC XY:
22
AN XY:
71680
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000173
AC:
7
AN:
40420
American (AMR)
AF:
0.000136
AC:
2
AN:
14724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5070
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4718
European-Finnish (FIN)
AF:
0.00149
AC:
14
AN:
9406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.000241
AC:
16
AN:
66338
Other (OTH)
AF:
0.000491
AC:
1
AN:
2036
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.281
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0812
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 4 Benign:1
Oct 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760322678; hg19: chr2-32366959; COSMIC: COSV59514150; API